Giuseppe Colloca
Giuseppe Colloca is an expert in Oncology at Agostino Gemelli University Polyclinic (Italy). Giuseppe Colloca has authored 149 publications, the most recent in 2026. SLR score: 427 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Radiotherapy - Geriatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 149
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Complete AV Block From Septal Cardiac Metastases of Anal Squamous Carcinoma Managed With Leadless Pacing. PMID 42799729 — atrioventricular block, carcinoma, squamous cell, neoplasm metastasis, wounds and injuries | JACC Case Rep | 2026 | 0 |
| Frailty and [ 177Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer. PMID 42707638 — nanomedicine, safety, neoplasms, prostate, prostatic neoplasms, castration, therapeutics, frailty | Theranostics | 2026 | 0 |
| A Narrative Review of da Vinci Single-Port Versus Multi-Port Robotic Surgery in Elderly or Frail Urological Cancer Patients. PMID 42588664 — bias, neoplasms, multiple chronic conditions, recycling, urologic neoplasms, aged, prostatic neoplasms, kidney neoplasms, geriatric assessment, frailty, postoperative complications | Cancers (Basel) | 2026 | 0 |
| Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort. PMID 40384151 — radiotherapy, intensity-modulated, radiotherapy, physics, breast neoplasms, neoplasms, neoplasm metastasis, breast, therapeutics, wounds and injuries | Acta Oncol | 2025 | 0 |
| Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan. PMID 40366333 — triple negative breast neoplasms, breast neoplasms, neoplasms, drug-related side effects and adverse reactions, breast | Oncologist | 2025 | 0 |
LeadR Networks
Main global connection map